Savara SVRA
NASDAQ SVRA
$4.54 -0.13 (-2.78%)
At close: Oct 22, 2026 · 4:00 PM EDT

Savara (SVRA) EBT Margin (2015 - 2026)

Updated

Savara (SVRA) reported EBT Margin of -1301200.00% for Q4 2020, down 1296987.11 percentage points from the prior quarter.

Analysis

Savara (SVRA) EBT Margin (2015 - 2026) Analysis & Trends

For FY2020, Savara posted EBT Margin of -19182.88%.

  • EBT Margin has a five-year change of -2518.06 percentage points (FY2015 to FY2020).
  • By year, EBT Margin came in at -2820.00% in FY2016 (+13844.81 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 0.13%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 25.18%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -4.11%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 29.63%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 18.19%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 27.53%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -131.41%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -4.34%
10 Savara 932.51 Mn 196.57 Mn - -4,941.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,941.50%
Mar 31, 2026 -3,688.74%
Dec 31, 2025 -2,796.57%
Sep 30, 2025 -5,520.99%
Jun 30, 2025 -3,413.68%
Mar 31, 2025 -1,778.30%
Dec 31, 2024 -1,629.59%
Sep 30, 2024 -1,238.00%
Dec 31, 2023 -1,160.63%
Dec 31, 2022 -1,771.17%
Dec 31, 2020 -1,301,200.00%
Sep 30, 2020 -4,212.89%
Sep 30, 2019 -248,060.00%
Jun 30, 2019 -70,770.97%
Dec 31, 2018 -11,124.79%
Sep 30, 2018 -11,315.32%
Mar 31, 2017 -5,543.62%
Dec 31, 2016 -1,081.25%
Sep 30, 2016 -7,171.11%
Dec 31, 2015 -22,520.37%
API Access

Savara EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=SVRA&period=max&api_key=YOUR_API_KEY